Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Topiramate NDC 68382-769 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

1ecf8c84 2838 464e 87cd 96511278d9e7 01

1ecf8c84 2838 464e 87cd 96511278d9e7 01

1ecf8c84 2838 464e 87cd 96511278d9e7 02

1ecf8c84 2838 464e 87cd 96511278d9e7 02

1ecf8c84 2838 464e 87cd 96511278d9e7 03

1ecf8c84 2838 464e 87cd 96511278d9e7 03

This text appears to be a section of a statistical analysis report, possibly related to a study on migraine treatments involving the drugs topiramate and placebo. The table lists the "Average Mosialy Migrane Period Rate (+E)" for each treatment dose (100 and 200 milligrams per day) and compares it to the "Chasge From Baselie o Double-Blnd Pass" (presumably a change from baseline in a double-blind test). The results show a statistically significant difference (p<0.001) between the topiramate and placebo groups.*

1ecf8c84 2838 464e 87cd 96511278d9e7 07

1ecf8c84 2838 464e 87cd 96511278d9e7 07

This is a medication called Topiramate that comes in the form of extended-release capsules with a dosage strength of 25mg. The capsules are to be swallowed whole and should not be opened, crushed, chewed, or added to food. It should be stored in a well-closed container at a controlled room temperature and kept away from moisture and light. The medication guide should be given to each patient, and this medication should be dispensed in a light container. The drug is manufactured by Cada Healthcare Ltd in India and distributed by Zydus Pharmaceuticals in the US.*

1ecf8c84 2838 464e 87cd 96511278d9e7 08

1ecf8c84 2838 464e 87cd 96511278d9e7 08

This is a description of a medication called Topiramate Extended-Release Capsules. The capsules should be swallowed whole and not opened or crushed. Each capsule contains 50mg of Topiramate USP in extended-release pellets. The medication guide should be provided to each patient by the pharmacist. The capsules should be stored at a controlled room temperature and protected from moisture and light. The medication is manufactured by Cadia Healthcare Limited in India and distributed by Zydus Pharmaceuticals in the USA. The packaging includes 30 capsules with the Rx-only mark of 77 Zydus.*

1ecf8c84 2838 464e 87cd 96511278d9e7 09

1ecf8c84 2838 464e 87cd 96511278d9e7 09

Topiramate is a medication that comes in the form of extended-release capsules. Each capsule contains 100mg of Topiramate USP as extended-release pellets. Patients are advised to swallow the capsules whole and not open, crush, or sprinkle the contents on food. Pharmacists should dispense the accompanying medication guide to their patients. The capsules should be stored in a well-closed container at a temperature of 20 to 25 degrees Celsius to protect them from moisture and light. Keep the capsules out of the reach of children. The medication is manufactured by Cadia Healthcare Limited in India and distributed by Zydus Pharmaceuticals in the USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.